Affentranger Associates
5
2M
4
0.25
3
0.20
2
- Areas of investment
Summary
Affentranger Associates appeared to be the Corporate Investor, which was created in 2002. The leading representative office of defined Corporate Investor is situated in the Zu00fcrich. The venture was found in Europe in Switzerland.
Among the most popular portfolio startups of the fund, we may highlight SIRS-Lab, InflaRx. Among the most successful fund investment fields, there are Recycling, Energy. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Affentranger Associates, startups are often financed by bm-t beteiligungsmanagement thu00fcringen. The meaningful sponsors for the fund in investment in the same round are bm-t beteiligungsmanagement thu00fcringen. In the next rounds fund is usually obtained by bm-t beteiligungsmanagement thu00fcringen, Swiss Helvetia Fund, Staidson Hongkong Investment.
The real fund results show that this Corporate Investor is 60 percentage points more often commits exit comparing to other companies. The increased amount of exits for fund were in 2017. Comparing to the other companies, this Affentranger Associates performs on 11 percentage points more the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2006. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 3
- Exits
- 2
- Rounds per year
- 0.25
- Follow on index
- 0.20
- Investments by industry
- Therapeutics (3)
- Pharmaceutical (2)
- Medical (2)
- Health Care (2)
- Mining (1) Show 11 more
- Investments by region
-
- Germany (3)
- Switzerland (2)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 0.40
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| InflaRx | 18 Mar 2008 | Health Care, Medical, Pharmaceutical, Therapeutics | Seed | Thuringia, Jena, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.